Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM-CHOC-PEN in CNS Malignancies
NCT02038218Phase 2Completed
- Sponsor
- DEKK-TEC, Inc.
- Start
- Sep 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mipicoledine in melanoma, lung cancer, breast cancer, glioblastoma (GBM), central nervous system cancer, sponsored by DEKK-TEC, Inc.. Started Sep 2013; status: completed.
02
Drugs
mipicoledine
03
Conditions
melanomalung cancerbreast cancerglioblastoma (GBM)central nervous system cancer
Beyond the preview
Go deeper on NCT02038218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038218.